LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here.
March 15, 2021 (LifeSiteNews) — A startup backed by Bill Gates is promising “rapid scaling” and manufacturing of problematic mRNA vaccines.
Nutcracker Therapeutics, a California biopharmaceutical company, allegedly is developing a new platform “that enables rapid discovery, development and manufacturing of mRNA therapies and vaccines,” according to a press release from September.
Novel mRNA vaccines involve injecting lab-based genetic material into the human body to make immune cells replicate certain viral components, ostensibly to fight against infections. The abortion-tainted Moderna and Pfizer COVID-19 jabs authorized for emergency use in the United States late last year are the first mRNA vaccines that have ever been brought to market.
Experts repeatedly have warned about potential dangers of the mRNA vaccine approach, including adverse autoimmune effects, systemic inflammation, and unknown genetic and fertility consequences. Nutcracker nevertheless has been working to ramp up production of future mRNA vaccines with accelerated manufacturing and “transformational” bio-chip innovations, the company claims.
“Founded in 2018, Nutcracker Therapeutics is bringing the combined power of high-technology engineering and advanced biosynthesis to RNA therapeutics,” Nutcracker’s September press release said.
The proprietary Nutcracker system, called ACORN, “is a first-of-its-kind, computer-controlled
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors